Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation.

MLA

Pengpeng Yan, et al. “Tamoxifen Attenuates Dialysate-Induced Peritoneal Fibrosis by Inhibiting GSK-3β/β-Catenin Axis Activation.” Bioscience Reports, vol. 38, no. 6, Dec. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1042/BSR20180240.

APA

Pengpeng Yan, Huanna Tang, Xiaoying Chen, Shuiyu Ji, Wei Jin, Jiaming Zhang, Jia Shen, Hao Deng, Xiang Zhao, Quanquan Shen, & Hongfeng Huang. (2018). Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation. Bioscience Reports, 38(6), 1–10. https://doi.org/10.1042/BSR20180240

Chicago

Pengpeng Yan, Huanna Tang, Xiaoying Chen, Shuiyu Ji, Wei Jin, Jiaming Zhang, Jia Shen, et al. 2018. “Tamoxifen Attenuates Dialysate-Induced Peritoneal Fibrosis by Inhibiting GSK-3β/β-Catenin Axis Activation.” Bioscience Reports 38 (6): 1–10. doi:10.1042/BSR20180240.